The Role of Transglutaminase 2 in Cancer: An Update.
breast cancer
colorectal cancer
leukemia
lung cancer
melanoma
microenvironment
ovarian cancer
pancreatic cancer
transglutaminase 2
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Feb 2024
28 Feb 2024
Historique:
received:
22
01
2024
revised:
25
02
2024
accepted:
26
02
2024
medline:
13
3
2024
pubmed:
13
3
2024
entrez:
13
3
2024
Statut:
epublish
Résumé
Transglutaminase type 2 (TG2) is the most ubiquitously expressed and well characterized member of the transglutaminase family. It is a ubiquitous multifunctional enzyme implicated in the regulation of several cellular pathways that support the survival, death, and general homeostasis of eukaryotic cells. Due to its multiple localizations both inside and outside the cell, TG2 participates in the regulation of many crucial intracellular signaling cascades in a tissue- and cell-specific manner, making this enzyme an important player in disease development and progression. Moreover, TG2 is capable of modulating the tumor microenvironment, a process of dynamic tissue remodeling and biomechanical events, resulting in changes which influence tumor initiation, growth, and metastasis. Even if generally related to the Ca
Identifiants
pubmed: 38474044
pii: ijms25052797
doi: 10.3390/ijms25052797
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Padua
ID : STARS2021 n°494876
Organisme : Italian Association for Cancer Research
ID : MFAG2019 n° 23271
Organisme : University of Padua
ID : BIRD162511
Organisme : Ministry of Education, Universities and Research
ID : PRIN 2022ACN7LZ
Organisme : Ministry of Education, Universities and Research
ID : CN00000041 - CUP C93C22002780006